TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 4 | 9 | 34 | 43 | 39 | 69 | 33 |
| P | %wins | 100 | 75 | 100 | 100 | 100 | 100 | 96 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/08 17:28 | 11/13/08 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Buchalter Jeffrey H | NJ | DO | CB,CEO,P | P | 164 | 3.28 | 2 | 50 | 12 | 453 | D | -62 | -69 | -66 | -67 | -56 | -41 | -38 | -30 | 6 | 15 | 75 | 113 | 98 | 210 |
8/21/07 12:22 | 8/20/07 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Buchalter Jeffrey H | NJ | DO | CB,CEO,P | P | 37 | 7.46 | 7 | 5 | 3 | 203 | D | 8 | -1 | -8 | -8 | 1 | 8 | 14 | 10 | 5 | 5 | 5 | 21 | 8 | 17 |
3/7/06 18:17 | 3/7/06 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Buchalter Jeffrey H | NJ | DO | CB,CEO,P | P | 69 | 6.86 | 2 | 10 | 11 | 98 | 2 | -1 | 23 | 8 | 19 | 16 | |||||||||
6/10/05 17:17 | 6/10/05 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Buchalter Jeffrey H | NJ | DO | CEO | P | 58 | 5.75 | 3 | 10 | 13 | 88 | D | -58 | -54 | -58 | -45 | -24 | -11 | -3 | 1 | 2 | 18 | 31 | 29 | 29 | 31 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |